A Phase 1, Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose, Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Emodepside (Primary)
- Indications Onchocerciasis
- Focus Adverse reactions; First in man
- 24 Aug 2017 Status changed from recruiting to completed.
- 31 Jan 2017 Planned End Date changed from 1 Nov 2016 to 1 Mar 2017.
- 31 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Mar 2017.